Stock NUMI NUMINUS WELLNESS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 10:06:40 2024-04-26 am EDT 		5-day change 1st Jan Change
0.075 CAD -6.25% Intraday chart for Numinus Wellness Inc. -11.76% -31.82%
Apr. 17 Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003 MT
Apr. 17 Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003 CI

Valuation

Fiscal Period: August 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 22.48 172.5 92.25 51.96 24.04 - -
Enterprise Value (EV) 1 22.48 172.5 92.25 51.96 24.04 24.04 24.04
P/E ratio -1.57 x - - -1.77 x -1.25 x -7.5 x 7.5 x
Yield - - - - - - -
Capitalization / Revenue 25.5 x 114 x 14.2 x 2.24 x 1.1 x 0.72 x 0.52 x
EV / Revenue 25.5 x 114 x 14.2 x 2.24 x 1.1 x 0.72 x 0.52 x
EV / EBITDA - -11,206,812 x -3,358,265 x - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 95,651 202,988 256,237 266,455 320,552 - -
Reference price 2 0.2350 0.8500 0.3600 0.1950 0.0750 0.0750 0.0750
Announcement Date 12/29/20 12/9/21 11/29/22 11/29/23 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.8812 1.514 6.494 23.18 21.91 33.35 46.06
EBITDA - -15.4 -27.47 - - - -
EBIT 1 - - -28.45 -29.52 -15.32 -3.372 4.032
Operating Margin - - -438.1% -127.36% -69.94% -10.11% 8.75%
Earnings before Tax (EBT) 1 - - - -30.26 -16.47 -3.372 4.032
Net income 1 - - - -30.26 -16.47 -3.372 4.032
Net margin - - - -130.53% -75.2% -10.11% 8.75%
EPS 2 -0.1500 - - -0.1100 -0.0600 -0.0100 0.0100
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 12/29/20 12/9/21 11/29/22 11/29/23 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 0.7896 0.7861 0.7411 4.177 5.668 5.355 6.027 6.131 5.946 5.031 5.465 5.464 6.761 8.004 8.959
EBITDA - - - -9.01 -6.288 - - - - - - - - - -
EBIT 1 - - - -9.638 -6.703 -7.093 -6.526 -8.624 -4.165 -5.045 -3.644 -2.469 - - -
Operating Margin - - - -230.72% -118.25% -132.47% -108.28% -140.66% -70.04% -100.28% -66.68% -45.19% - - -
Earnings before Tax (EBT) 1 - - - - - -7.293 -7.28 -9.386 -4.406 -5.954 -3.644 -2.469 - - -
Net income 1 - - - - - -7.331 -7.289 -9.338 -4.406 -5.954 -3.644 -2.469 - - -
Net margin - - - - - -136.92% -120.94% -152.32% -74.11% -118.35% -66.68% -45.19% - - -
EPS 2 - - - - - -0.0300 -0.0300 -0.0300 -0.0200 -0.0200 -0.0100 -0.0100 - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 1/20/22 4/14/22 7/14/22 11/29/22 1/16/23 4/13/23 7/17/23 11/29/23 1/15/24 4/13/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: August 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - 1.25 - - - -
Capex / Sales - - 19.19% - - - -
Announcement Date 12/29/20 12/9/21 11/29/22 11/29/23 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Numinus Wellness Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.075
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
NUMINUS WELLNESS INC. Stock Numinus Wellness Inc.
-31.82% 17.56M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NUMI Stock
  4. Financials Numinus Wellness Inc.